November 10, 2019

Brand Medications with Generic Alternatives Anticipated to be Approved in December

Read More
November 8, 2019

Reblozyl Approved to Treat Rare Blood Disorder

Read More
November 7, 2019

First Biosimilar for Rituxan Launched

Read More
November 5, 2019

Ziextenzo Approved as Biosimilar to Neulasta

Read More
November 4, 2019

New Quadrivalent High-Dose Flu Vaccine Approved

Read More
November 4, 2019

Talicia Approved to Treat H. pylori Infections

Read More
October 29, 2019

Vumerity Approved to Treat Multiple Sclerosis

Read More
October 28, 2019

Liletta Approval Expanded to Prevent Pregnancy for Six Years

Read More
October 25, 2019

Mylan Recalls One Lot of Alprazolam

Read More
October 24, 2019

Baxdela Receives New Indication to Treat Pneumonia

Read More
October 24, 2019

Update on NDMA Impurities in Ranitidine

Read More
October 23, 2019

Zejula Receives New Indication for Advanced Ovarian Cancer

Read More